To whom should C losses be reported?

C losses refer to the loss of controlled substances that are classified as Schedule III, IV, and V drugs. The proper reporting of these losses is crucial for complying with federal and state regulations regarding the handling of controlled substances.

When a pharmacy discovers a loss of controlled substances, it is required to report this to both the Board of Pharmacy (BOP) and the Drug Enforcement Administration (DEA). The BOP is the state regulatory body responsible for overseeing pharmacy practice and ensuring compliance with Minnesota’s regulations, while the DEA handles the federal regulations pertaining to controlled substances. Reporting to both of these authorities helps ensure that appropriate measures are taken to address the loss, investigate potential causes, and prevent future occurrences.

The other options, while they may have their own relevance in various contexts, do not fulfill the reporting requirement for C losses. Local authorities may not have jurisdiction over controlled substance losses, and while state governments and pharmacy associations play important roles in pharmacy oversight and advocacy, they are not the appropriate entities for reporting specific losses of controlled substances. Therefore, the correct approach to reporting C losses specifically involves notifying both the BOP and the DEA.